Trifluridine
ATC S01AD02 · 9 markets · 35 records
AU 7 records · 3 strengths
- 20 mgtabletLonsurf 20/8.19LONSURF 20/8.19 trifluridine 20 mg/ tipiracil hydrochloride 9.420 mg (equivalent to tipiracil 8.19 mg) film-coated tablet blister pack、ORCANTAS 20/8.19 trifluridine 20 mg/ tipiracil hydrochloride 9.420 mg (equivalent to tipiracil 8.19 mg) film-coated tablet blister pack
- 15 mgtabletLonsurf 15/6.14LONSURF 15/6.14 trifluridine 15 mg/ tipiracil hydrochloride 7.065 mg (equivalent to tipiracil 6.14 mg) film-coated tablet blister pack、ORCANTAS 15/6.14 trifluridine 15 mg/ tipiracil hydrochloride 7.065 mg (equivalent to tipiracil 6.14 mg) film-coated tablet blister pack
Records without a stated strength · 1 LONSURF
GB 5 records · 3 strengths
Records without a stated strength · 1 Viroptic 1% eye drops、Manufacturer: Special Order
ES 4 records · 2 strengths
US 3 records · 3 strengths
CA 3 records · 3 strengths
SG 2 records · 2 strengths
TW 2 records · 1 strengths
Records without a stated strength · 1 LONSURF、朗斯弗膜衣錠15毫克、朗斯弗膜衣錠20毫克
HK 2 records · 1 strengths
Records without a stated strength · 1 LONSURF
EU 1 records · 1 strengths
EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.
Records without a stated strength · 1 LONSURF
| Strength / form / release | US | GB | CA | AU | SG | ES | TW | HK | EU |
|---|---|---|---|---|---|---|---|---|---|
| 20 mg tablet | LONSURF | LONSURF | LONSURF | Lonsurf 20/8.19 LONSURF 20/8.19 trifluridine 20 mg/ tipiracil hydrochloride 9.420 mg (equivalent to tipiracil 8.19 mg) film-coated tablet blister pack ORCANTAS 20/8.19 trifluridine 20 mg/ tipiracil hydrochloride 9.420 mg (equivalent to tipiracil 8.19 mg) film-coated tablet blister pack | LONSURF | LONSURF | |||
| 15 mg tablet | LONSURF | LONSURF | LONSURF | Lonsurf 15/6.14 LONSURF 15/6.14 trifluridine 15 mg/ tipiracil hydrochloride 7.065 mg (equivalent to tipiracil 6.14 mg) film-coated tablet blister pack ORCANTAS 15/6.14 trifluridine 15 mg/ tipiracil hydrochloride 7.065 mg (equivalent to tipiracil 6.14 mg) film-coated tablet blister pack | LONSURF | LONSURF | |||
| 10 mg liquid | Manufacturer: Sandoz Inc | ||||||||
| 1 % liquid | APO-TRIFLURIDINE | ||||||||
tablet | LONSURF 朗斯弗膜衣錠15毫克 朗斯弗膜衣錠20毫克 | ||||||||
unknown | LONSURF | LONSURF | LONSURF | ||||||
liquid | Manufacturer: Special Order ×2 Viroptic 1% eye drops |
Scroll horizontally for more markets →
Each country column shows the locally registered trade names — not translations.
2 more strength/form rows are recorded only in CA · TW and are not shown in this table. Hay 2 filas de concentración/forma registradas solo en CA · TW que no se muestran en esta tabla. 另有 2 个规格/剂型仅在 CA · TW 有记录（未在本表显示）。 另有 2 個規格/劑型僅在 CA · TW 有記錄（未在本表顯示）。
“not disclosed” means the source does not publish the strength — it does not mean the product has none.
Hong Kong records are name/ingredient-level only: no strength, dosage form or registration status; on the register does not prove current supply.
Australia ARTG data has no registration-status column, so status is shown as unknown; being on the register does not mean currently marketed.
EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.
Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.